|Bid price||595.00||Open price||592.00|
|Ask price||595.50||Prev close||595.00|
Register now for FREE live Abcam share prices, Abcam stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Abcam Level 2 Data, indepth research tools and investor commentary for Abcam (ABC) and other London Stock Exchange equities.
Register now for FREE Abcam share price charts
|Sector||Pharmaceuticals & Biotechnology||ISIN||GB00B6774699|
|Activites||Abcam plc is a leading provider of protein research tools and services, with a wide range of products and expert technical support, enabling scientists to analyse living cells at the molecular level and improving the understanding of health and disease.||Index||n/a|
|Latest Share Price (p)||595.00||Net Gearing (%)||-8.49|
|Market Capitalisation (£m)||1,196.45||Gross Gearing (%)||14.34|
|Shares in issue (m)||202.44||Debt Ratio||6.46|
|P/E Ratio||31.62||Debt-to-Equity Ratio||0.41|
|Total dividends per share (p)||8.21||Assets / Equity Ratio||1.17|
|Dividend Yield (%)||1.41||Price to book value||5.59|
|Dividend cover (x)||2.18||ROCE (%)||20.14|
|Earning per share (p)||18.69||EPS Growth (%)||9.17|
|52 week high / low||690.00 / 493.75||DPS Growth (%)||5.94|
|Dec.Date||Type||Director||Pos||No. of Shares|
/* */ RNS Number : 0922X ABCAM Plc 03 May 2016 For immediate release 3 May 2016 ABCAM PLC ( "Abcam" or "Company" ) Total Voting Rights - Voting Rights and Capital In conformity with the Disclosure Rules...
Jeffrey Iliffe, Financial Director, has re-invested 79 shares in the company on the 18th April 2016 at a price of 602.00p. The Director now holds 327,885 shares. NOTE: SIP Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com
Jim Warwick, Executive Director, has re-invested 79 shares in the company on the 18th April 2016 at a price of 602.00p. The Director now holds 2,943,381 shares. NOTE: SIP Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com
Register now for FREE Abcam company news
Abcam markets research-grade antibodies to academic and commercial users and is headquartered in Cambridge, UK, with a US office in Cambridge, Massachusetts. Its online catalogue of more than 17,000 products is supported by continually updated technical data created by the Company. *...
Everytime I go from one page to another this stupid site logs me out. Stockwatch is particularly bad. Even when I am already logged in it asks me to log in again, and then takes me not to stockwatch but to the homepage. THIS IS INFURIATING!!! I will never pay for any service offered by this site...
Pickings a bit thin on the ground this week and I must admit that my trawl thru the S&P 500 was a bit half hearted. However, this one looks set for a trip back down after failing to make new highs, breaking suport at $52ish and forming, throughout 2002, what looks suspiciously like a shallow head...
Register now for FREE Abcam share price discussions